Mabel Ryder
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 34
- Oncology 23
- Cancer Immunotherapy and Biomarkers 13
- Cancer-related Molecular Pathways 6
- Co-authors
- James A. Fagin (11 shared papers)Camilo Jiménez (2 shared papers)Jeffrey A. Knauf (8 shared papers)Ronald Ghossein (7 shared papers)Maria E. Cabanillas (2 shared papers)Lisa A. Kottschade (6 shared papers)Keith C. Bible (13 shared papers)Jedd D. Wolchok (1 shared paper)
- Journals
- Thyroid (9 papers)The Journal of Clinical Endocrinology & Metabolism (5 papers)Endocrine Related Cancer (2 papers)Cancer Research (2 papers)The Lancet Diabetes & Endocrinology (2 papers)
- Partner nations
- United StatesCanadaNorway
In The Last Decade
Mabel Ryder
53 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 88
- Endocrinology, Diabetes and Metabolism 1.5k
- Oncology 1.3k
- Cancer Research 249
- Neurology 206
- Immunology 275
Countries citing papers authored by Mabel Ryder
This map shows the geographic impact of Mabel Ryder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mabel Ryder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mabel Ryder more than expected).
Fields of papers citing papers by Mabel Ryder
This network shows the impact of papers produced by Mabel Ryder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mabel Ryder. The network helps show where Mabel Ryder may publish in the future.
Co-authors
The 25 scholars most cited alongside Mabel Ryder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 420 | |
| 2 | 2014 | 344 | |
| 3 | 2011 | 286 | |
| 4 | 2019 | 241 | |
| 5 | 2017 | 195 | |
| 6 | 2019 | 123 | |
| 7 | 2013 | 116 | |
| 8 | 2017 | 103 | |
| 9 | 2021 | 88 | |
| 10 | 2016 | 63 | |
| 11 | 2019 | 57 | |
| 12 | 2020 | 54 | |
| 13 | 2016 | 51 | |
| 14 | 2013 | 51 | |
| 15 | 2020 | 39 | |
| 16 | 2016 | 29 | |
| 17 | 2021 | 29 | |
| 18 | 2017 | 28 | |
| 19 | 2021 | 27 | |
| 20 | 2023 | 23 |
About Mabel Ryder
Mabel Ryder is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Surgery, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 57 papers that have together received 2.6k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (34 papers), Cancer Immunotherapy and Biomarkers (13 papers), Thyroid and Parathyroid Surgery (6 papers), Cancer-related Molecular Pathways (6 papers), Neuroendocrine Tumor Research Advances (6 papers), Cancer, Hypoxia, and Metabolism (5 papers), Adrenal and Paraganglionic Tumors (5 papers) and BRCA gene mutations in cancer (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.5k citations), Oncology (1.3k citations), Cancer Research (249 citations), Neurology (206 citations) and Immunology (275 citations). Mabel Ryder has collaborated with scholars based in United States, Canada and Norway. Frequent co-authors include James A. Fagin, Camilo Jiménez, Jeffrey A. Knauf, Ronald Ghossein, Maria E. Cabanillas, Lisa A. Kottschade, Keith C. Bible, Jedd D. Wolchok, Michael A. Postow and Margaret K. Callahan. Their work appears in journals such as Thyroid, The Journal of Clinical Endocrinology & Metabolism, Endocrine Related Cancer, Cancer Research and The Lancet Diabetes & Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.